Imunizasaun Agora Proteje Labarik Sira

The vaccine, which combines protection against five serious diseases, is designed to provide a strong defense against Hib (Haemophilus influenza type B) and other serious illnesses. Hib is a leading cause of meningitis, a severe and potentially life-threatening infection that can leave children with long-term disabilities. The introduction of the pentavalent vaccine is expected to reduce the incidence of Hib-related illnesses and deaths in Timor-Leste. The pentavalent vaccine is a new addition to the country's routine immunization program, which is administered to children at six, ten, and fourteen weeks of age, and at nine months. The vaccine is given in three doses, with the first dose administered at six weeks, the second dose at ten weeks, and the third dose at fourteen weeks. The vaccine is also given at nine months, as part of the country's expanded program on immunization. The introduction of the pentavalent vaccine is a major breakthrough in the fight against serious diseases in Timor-Leste. The vaccine provides protection against Hib, as well as diphtheria, pertussis, tetanus, and hepatitis B. The vaccine is safe and effective, and has been shown to reduce the risk of serious illnesses and deaths in children. The Ministry of Health in Timor-Leste has introduced the pentavalent vaccine as part of its efforts to improve the health and well-being of children in the country. The vaccine is a key component of the country's immunization program, which aims to protect children against serious diseases and promote their overall health and development. The introduction of the pentavalent vaccine is a significant step forward in the country's efforts to reduce the burden of serious diseases on children and families. The vaccine is a valuable tool in the fight against Hib and other serious illnesses, and is expected to have a major impact on the health and well-being of children in Timor-Leste. The pentavalent vaccine is administered as part of the country's routine immunization program, which is designed to protect children against serious diseases from birth to five years of age. The vaccine is given in a series of doses, with the first dose administered at six weeks, the second dose at ten weeks, and the third dose at fourteen weeks. The vaccine is also given at nine months, as part of the country's expanded program on immunization. The introduction of the pentavalent vaccine is a major achievement for the Ministry of Health in Timor-Leste, and is expected to have a significant impact on the health and well-being of children in the country. The vaccine is a key component of the country's immunization program, and is designed to provide a strong defense against serious diseases and promote the overall health and development of children.